These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 1939384

  • 1. L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.
    Melega WP, Grafton ST, Huang SC, Satyamurthy N, Phelps ME, Barrio JR.
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):890-7. PubMed ID: 1939384
    [Abstract] [Full Text] [Related]

  • 2. Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
    Huang SC, Yu DC, Barrio JR, Grafton S, Melega WP, Hoffman JM, Satyamurthy N, Mazziotta JC, Phelps ME.
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):898-913. PubMed ID: 1939385
    [Abstract] [Full Text] [Related]

  • 3. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
    Hoffman JM, Melega WP, Hawk TC, Grafton SC, Luxen A, Mahoney DK, Barrio JR, Huang SC, Mazziotta JC, Phelps ME.
    J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
    [Abstract] [Full Text] [Related]

  • 4. The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans.
    Melega WP, Hoffman JM, Luxen A, Nissenson CH, Phelps ME, Barrio JR.
    Life Sci; 1990 Aug; 47(2):149-57. PubMed ID: 2117691
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
    Cumming P, Léger GC, Kuwabara H, Gjedde A.
    J Cereb Blood Flow Metab; 1993 Jul; 13(4):668-75. PubMed ID: 8314919
    [Abstract] [Full Text] [Related]

  • 6. PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.
    Kumakura Y, Vernaleken I, Gründer G, Bartenstein P, Gjedde A, Cumming P.
    J Cereb Blood Flow Metab; 2005 Jul; 25(7):807-19. PubMed ID: 15729292
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.
    Melega WP, Luxen A, Perlmutter MM, Nissenson CH, Phelps ME, Barrio JR.
    Biochem Pharmacol; 1990 Jun 15; 39(12):1853-60. PubMed ID: 2112915
    [Abstract] [Full Text] [Related]

  • 8. Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects.
    Kuwabara H, Cumming P, Reith J, Léger G, Diksic M, Evans AC, Gjedde A.
    J Cereb Blood Flow Metab; 1993 Jan 15; 13(1):43-56. PubMed ID: 8417009
    [Abstract] [Full Text] [Related]

  • 9. 6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.
    Barrio JR, Huang SC, Melega WP, Yu DC, Hoffman JM, Schneider JS, Satyamurthy N, Mazziotta JC, Phelps ME.
    J Neurosci Res; 1990 Dec 15; 27(4):487-93. PubMed ID: 2127807
    [Abstract] [Full Text] [Related]

  • 10. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
    Danielsen EH, Smith DF, Gee AD, Venkatachalam TK, Hansen SB, Hermansen F, Gjedde A, Cumming P.
    Synapse; 1999 Sep 15; 33(4):247-58. PubMed ID: 10421705
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Metabolites of 6-[18F]fluoro-L-dopa in human blood.
    Firnau G, Sood S, Chirakal R, Nahmias C, Garnett ES.
    J Nucl Med; 1988 Mar 15; 29(3):363-9. PubMed ID: 3126278
    [Abstract] [Full Text] [Related]

  • 14. Metabolism and blood-brain clearance of L-3,4-dihydroxy-[3H]phenylalanine ([3H]DOPA) and 6-[18F]fluoro-L-DOPA in the rat.
    Cumming P, Ase A, Diksic M, Harrison J, Jolly D, Kuwabara H, Laliberté C, Gjedde A.
    Biochem Pharmacol; 1995 Sep 28; 50(7):943-6. PubMed ID: 7575677
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis and evaluation of an 18F-labeled dopa prodrug as a PET tracer for studying brain dopamine metabolism.
    Ishiwata K, Shinoda M, Ishii S, Nozaki T, Senda M.
    Nucl Med Biol; 1996 Apr 28; 23(3):295-301. PubMed ID: 8782240
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Developmental changes in the activities of aromatic amino acid decarboxylase and catechol-O-methyl transferase in the porcine brain: a positron emission tomography study.
    Brust P, Walter B, Hinz R, Füchtner F, Müller M, Steinbach J, Bauer R.
    Neurosci Lett; 2004 Jul 08; 364(3):159-63. PubMed ID: 15196667
    [Abstract] [Full Text] [Related]

  • 19. Cerebral 6-[18F]fluoro-L-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition.
    Psylla M, Günther I, Antonini A, Vontobel P, Reist HW, Zollinger A, Leenders KL.
    Brain Res; 1997 Aug 29; 767(1):45-54. PubMed ID: 9365014
    [Abstract] [Full Text] [Related]

  • 20. 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism and positron emission tomography after catechol-O-methyltransferase inhibition in normal and hemiparkinsonian monkeys.
    Miletich RS, Comi G, Bankiewicz K, Plunkett R, Adams R, Di Chiro G, Kopin IJ.
    Brain Res; 1993 Oct 29; 626(1-2):1-13. PubMed ID: 8281420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.